Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists: An executive summary

被引：0

作者：

Sherman, Elizabeth M. ^{[1
,2
]}

Agwu, Allison L. ^{[3
]}

Ambrosioni, Juan ^{[4
,5
,6
,7
,8
]}

Behrens, Georg M. N. ^{[9
,10
,11
]}

Chu, Carolyn ^{[12
]}

Collins, Lauren F. ^{[13
]}

Jimenez, Humberto R. ^{[14
,15
]}

Koren, David E. ^{[16
]}

McGorman, Leslie ^{[17
,28
]}

Nguyen, Nancy N. ^{[18
]}

Nicol, Melanie R. ^{[19
]}

Pandit, Neha Sheth ^{[20
]}

Pierre, Natacha ^{[21
]}

Scarsi, Kimberly K. ^{[22
]}

Spinner, Gary F. ^{[23
]}

Tseng, Alice ^{[24
,25
]}

Young, Jeremy D. ^{[26
]}

Badowski, Melissa E. ^{[27
]}

机构：

[1] Nova Southeastern Univ, Barry & Judy Silverman Coll Pharm, Ft Lauderdale, FL 33328 USA

[2] Mem Healthcare Syst, Div Infect Dis, Hollywood, FL USA

[3] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD USA

[4] Hosp Clin Barcelona, HIV Unit, Barcelona, Spain

[5] Hosp Clin Barcelona, Infect Dis Serv, Barcelona, Spain

[6] Fundacio Recerca Clin Barcelona IDIBAPS, Barcelona, Spain

[7] Univ Barcelona, Barcelona, Spain

[8] Inst Salud Carlos III, CIBERINFEC, Madrid, Spain

[9] Hannover Med Sch, Dept Rheumatol & Immunol, Hannover, Germany

[10] German Ctr Infect Res DZ, Partner Site Hannover Braunschweig, Hannover, Germany

[11] Hannover Med Sch, Ctr Individualized Infect Med CiiM, Hannover, Germany

[12] Univ Calif San Francisco, San Francisco, CA USA

[13] Grady Ponce de Leon Ctr, Emory Sch Med, Div Infect Dis, Atlanta, GA USA

[14] Rutgers State Univ, Ernest Mario Sch Pharm, Piscataway, NJ USA

[15] St Josephs Univ, Comprehens Care Ctr, Med Ctr, Paterson, NJ USA

[16] Temple Univ Hlth Syst, Philadelphia, PA USA

[17] Amer Acad HIV Med, Washington, DC USA

[18] Univ Pacific, Thomas J Long Sch Pharm, Stockton, CA USA

[19] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN USA

[20] Univ Maryland Baltimore, Sch Pharm, Dept Practice Sci & Hlth Outcomes Res, Baltimore, MD USA

[21] Univ Illinois, Coll Nursing, Dept Populat Hlth Nursing Sci, Chicago, IL USA

[22] Univ Nebraska Med Ctr, Coll Pharm, Dept Pharm Practice & Sci, Omaha, NE USA

[23] Southwest Community Hlth Ctr, Bridgeport, CT USA

[24] Univ Hlth Network, Immunodeficiency Clin, Toronto, ON, Canada

[25] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada

[26] Ohio State Univ, Wexner Med Ctr, Div Infect Dis, Columbus, OH USA

[27] Univ Illinois, Coll Pharm, Chicago, IL USA

[28] AIDS United, Washington, DC USA

来源：

PHARMACOTHERAPY | 2024年 / 44卷 / 07期

关键词：

antiretrovirals; HIV; long acting; pre-exposure prophylaxis; prevention; treatment; ANTITUMOR NECROSIS FACTOR; SERIOUS BACTERIAL-INFECTIONS; PROPENSITY SCORE METHODS; RHEUMATOID-ARTHRITIS; RISK; HOSPITALIZATION; THERAPY; SURVIVAL;

D O I：

10.1002/phar.2921

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Five long-acting (LA) antiretrovirals (ARVs) are currently available in a limited number of countries worldwide for HIV-1 prevention or treatment - cabotegravir, rilpivirine, lenacapavir, ibalizumab, and dapivirine. Implementing use of LA ARVs in routine clinical practice requires significant changes to the current framework of HIV-1 prevention, treatment, and service provision. Given the novelty, complexity, and interdisciplinary requirements of safe and optimal use of LA ARVs, consensus recommendations on the use of LA ARVs will assist clinicians in optimizing use of these agents. The purpose of these recommendations is to provide guidance for the clinical use of LA ARVs for HIV-1 treatment and prevention. In addition, future areas of research are identified and discussed.

引用

页码：488 / 493

页数：6

共 8 条

[1] Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy: An executive summary
Cluck, David B.
Chastain, Daniel B.
Murray, Milena
Durham, Spencer H.
Chahine, Elias B.
Derrick, Caroline
Dumond, Julie B.
Hester, E. Kelly
Jeter, Sarah B.
Johnson, Melissa D.
Kilcrease, Christin
Kufel, Wesley D.
Kwong, Jeffrey
Ladak, Amber F.
Patel, Nimish
Perez, Sarah E.
Poe, Jonell B.
Bolch, Charlotte
Thomas, Ian
Asiago-Reddy, Elizabeth
Short, William R.
PHARMACOTHERAPY, 2024, 44 (05): : 354 - 359
[2] International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists
Hong, Lisa T.
Downes, Kevin J.
Fakhriravari, Alireza
Abdul-Mutakabbir, Jacinda C.
Kuti, Joseph L.
Jorgensen, Sarah
Young, David C.
Alshaer, Mohammad H.
Bassetti, Matteo
Bonomo, Robert A.
Gilchrist, Mark
Jang, Soo Min
Lodise, Thomas
Roberts, Jason A.
Tangden, Thomas
Zuppa, Athena
Scheetz, Marc H.
PHARMACOTHERAPY, 2023, 43 (08): : 740 - 777
[3] Comment on 'international consensus recommendations for the use of prolonged-infusion β-lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the infectious diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists'
Cobenas, Carlos Augusto Espinoza
PHARMACOTHERAPY, 2024, 44 (02): : 207 - 207
[4] Response to comment on "International consensus recommendations for the use of prolonged-infusion β-lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists"
Hong, Lisa T.
Downes, Kevin J.
Fakhriravari, Alireza
Abdul-Mutakabbir, Jacinda C.
Kuti, Joseph L.
Jorgensen, Sarah
Young, David C.
Alshaer, Mohammad H.
Bassetti, Matteo
Bonomo, Robert A.
Gilchrist, Mark
Jang, Soo Min
Lodise, Thomas
Roberts, Jason A.
Taengden, Thomas
Zuppa, Athena
Scheetz, Marc H.
PHARMACOTHERAPY, 2024, 44 (02): : 208 - 209
[5] International Consensus Guidelines for the Optimal Use of the Polymyxins Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Tsuji, Brian T.
Pogue, Jason M.
Zavascki, Alexandre P.
Paul, Mical
Daikos, George L.
Forrest, Alan
Giacobbe, Daniele R.
Viscoli, Claudio
Giamarellou, Helen
Karaiskos, Llias
Kaye, Donald
Mouton, Johan W.
Tam, Vincent H.
Thamlikitkul, Visanu
Wunderink, Richard G.
Li, Jian
Nation, Roger L.
Kaye, Keith S.
PHARMACOTHERAPY, 2019, 39 (01): : 10 - 39
[6] International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists (vol 43, pg 740, 2023)
Hong, L. T.
Downes, K. J.
FakhriRavari, A.
PHARMACOTHERAPY, 2024, 44 (09): : 755 - 759
[7] International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists (vol 43, pg 740, 2023)
Hong, L. T.
Downes, K. J.
FakhriRavar, A.
PHARMACOTHERAPY, 2024, 44 (09): : 754 - 754
[8] Executive Summary: Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children Recommendations From the National Institutes of Health, the Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics
Siberry, George K.
Abzug, Mark J.
Nachman, Sharon
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2013, 2 (04) : 293 - 308

← 1 →